DYNLL1 INHIBITS DNA END RESECTION IN BRCA1-DEFICIENT CELLS AND REGULATES PARP INHIBITOR SENSITIVITY

被引：0
|
作者：
He, Yizhou Joseph [1 ]
Meghani, Khyati [1 ]
Caron, Marie-Christine [2 ,3 ]
Yang, Chunyu [1 ]
Ronato, Daryl A. [2 ,3 ]
Bian, Jie [1 ]
Sharma, Anchal [4 ]
Miller, Jessica [1 ]
Joshi, Niraj [1 ]
Detappe, Alexandre [5 ]
Doench, John G. [6 ]
Legube, Gaelle [7 ]
Root, David E. [6 ]
D'Andrea, Alan D. [1 ,8 ]
Drane, Pascal [1 ]
De, Subhojyoti [4 ]
Konstantinopoulos, Panagiotis [5 ]
Masson, Jean-Yves [2 ,3 ]
Chowdhury, Dipanjan [1 ,6 ,9 ]
机构：
[1] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Radiat & Genome Stabil, Boston, MA 02215 USA
[2] CHU Quebec Res Ctr, Genome Stabil Lab, Oncol Axis, HDQ Pavil,9 McMahon, Quebec City, PQ G1R 2J6, Canada
[3] Laval Univ, Canc Res Ctr, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1V 0A6, Canada
[4] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[5] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[6] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[7] Univ Toulouse, CNRS, CBI, LBCMCP,UT3, 118 Route Narbonne, F-31062 Toulouse, France
[8] Harvard Med Sch, Dana Farber Canc Inst, Ctr DNA Damage & Repair, Boston, MA 02215 USA
[9] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GMM-027
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [1] DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells
    He, Yizhou Joseph
    Meghani, Khyati
    Caron, Marie-Christine
    Yang, Chunyu
    Ronato, Daryl A.
    Bian, Jie
    Sharma, Anchal
    Moore, Jessica
    Niraj, Joshi
    Detappe, Alexandre
    Doench, John G.
    Legube, Gaelle
    Root, David E.
    D'Andrea, Alan D.
    Drane, Pascal
    De, Subhajyoti
    Konstantinopoulos, Panagiotis A.
    Masson, Jean-Yves
    Chowdhury, Dipanjan
    NATURE, 2018, 563 (7732) : 522 - +
  • [2] DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells
    Yizhou Joseph He
    Khyati Meghani
    Marie-Christine Caron
    Chunyu Yang
    Daryl A. Ronato
    Jie Bian
    Anchal Sharma
    Jessica Moore
    Joshi Niraj
    Alexandre Detappe
    John G. Doench
    Gaelle Legube
    David E. Root
    Alan D. D’Andrea
    Pascal Drané
    Subhajyoti De
    Panagiotis A. Konstantinopoulos
    Jean-Yves Masson
    Dipanjan Chowdhury
    Nature, 2018, 563 : 522 - 526
  • [3] FUNCTIONAL HETEROGENEITY OF ACQUIRED PARP INHIBITOR RESISTANCE IN BRCA1-DEFICIENT CELLS
    Farkkila, Anniina
    Rodriquez, Alfredo
    Olkkonen, Jaana
    Sambel, Larissa
    Dominiquez, Julieta
    Joshi, Niraj
    Clairmont, Connor
    Zhou, Jia
    Lim, Kah-Suan
    Hautaniemi, Sampsa
    D'Andrea, Alan
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 204 - 204
  • [4] The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells
    Barazas, Marco
    Annunziato, Stefano
    Pettitt, Stephen J.
    de Krijger, Inge
    Ghezraoui, Hind
    Roobol, Stefan J.
    Lutz, Catrin
    Frankum, Jessica
    Song, Fei Fei
    Brough, Rachel
    Evers, Bastiaan
    Gogola, Ewa
    Bhin, Jinhyuk
    van de Ven, Marieke
    van Gent, Dik C.
    Jacobs, Jacqueline J. L.
    Chapman, Ross
    Lord, Christopher J.
    Jonkers, Jos
    Rottenberg, Sven
    CELL REPORTS, 2018, 23 (07): : 2107 - 2118
  • [5] 53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
    Bunting, Samuel F.
    Callen, Elsa
    Wong, Nancy
    Chen, Hua-Tang
    Polato, Federica
    Gunn, Amanda
    Bothmer, Anne
    Feldhahn, Niklas
    Fernandez-Capetillo, Oscar
    Cao, Liu
    Xu, Xiaoling
    Deng, Chu-Xia
    Finkel, Toren
    Nussenzweig, Michel
    Stark, Jeremy M.
    Nussenzweig, Andre
    CELL, 2010, 141 (02) : 243 - 254
  • [6] Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability
    Whalen, Jenna M.
    Earley, Jillian
    Wisniewski, Christi
    Mercurio, Arthur M.
    Cantor, Sharon B.
    NATURE CANCER, 2025, 6 (02) : 278 - 291
  • [7] The USP1 inhibitor I-138 kills BRCA1-deficient tumor cells and overcomes PARP inhibitor resistance
    Da Costa, Alexandre Andre B. A.
    Bose, Arindam
    Martignetti, David
    Ayala-Zambrano, Cecilia
    Ravindranathan, Ramya
    Sadatrezaei, Golbahar
    Jiao, Yuqing
    Kochupurakkal, Bose
    Nguyen, Huy
    Lazaro, Jean-Bernard
    Parmar, Kalindi
    Shapiro, Geoffrey I.
    D'Andrea, Alan D.
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1-Deficient Cells
    Farkkila, Anniina
    Rodriguez, Alfredo
    Oikkonen, Jaana
    Gulhan, Doga C.
    Huy Nguyen
    Dominguez, Julieta
    Ramos, Sandra
    Mills, Caitlin E.
    Perez-Villatoro, Fernando
    Lazaro, Jean-Bernard
    Zhou, Jia
    Clairmont, Connor S.
    Moreau, Lisa A.
    Park, Peter J.
    Sorger, Peter K.
    Hautaniemi, Sampsa
    Frias, Sara
    D'Andrea, Alan D.
    CANCER RESEARCH, 2021, 81 (10) : 2774 - 2787
  • [9] Dynamics of the DYNLL1–MRE11 complex regulate DNA end resection and recruitment of Shieldin to DSBs
    Michelle L. Swift
    Rui Zhou
    Aleem Syed
    Lisa A. Moreau
    Bartłomiej Tomasik
    John A. Tainer
    Panagiotis A. Konstantinopoulos
    Alan D. D’Andrea
    Yizhou Joseph He
    Dipanjan Chowdhury
    Nature Structural & Molecular Biology, 2023, 30 : 1456 - 1467
  • [10] Intermittent treatment with the PARP inhibitor olaparib delays tumor development in BRCA1-deficient mice
    Liby, Karen T.
    To, Ciric
    CANCER RESEARCH, 2014, 74 (23)
12345